Production (Stage)
Evogene Ltd.
EVGN
$1.38
-$0.14-9.21%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -19.87M | -21.47M | -23.88M | -20.28M |
| Total Depreciation and Amortization | -- | 2.61M | 2.64M | 2.61M | 2.59M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 1.11M | 1.22M | 90.00K | 398.00K |
| Change in Net Operating Assets | -- | -3.66M | -1.83M | -400.00K | -621.00K |
| Cash from Operations | -- | -19.81M | -19.44M | -21.58M | -17.91M |
| Capital Expenditure | -- | -474.00K | -567.00K | -785.00K | -898.00K |
| Sale of Property, Plant, and Equipment | -- | 10.00K | 10.00K | 26.00K | 26.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 2.37M | -8.65M | -3.78M | -3.53M |
| Cash from Investing | -- | 1.91M | -9.20M | -4.54M | -4.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -885.00K | -861.00K | -836.00K | -1.06M |
| Issuance of Common Stock | -- | 8.20M | 8.18M | 8.45M | 8.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -180.00K | 10.41M | 10.54M | 10.58M |
| Cash from Financing | -- | 7.13M | 17.73M | 18.15M | 17.94M |
| Foreign Exchange rate Adjustments | -- | 18.00K | -170.00K | -245.00K | -164.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -10.75M | -11.09M | -8.21M | -4.53M |